Education
About Us
Working with TipRanks
Follow Us
Regeneron (REGN)
NASDAQ:REGN
REGN Analyst Ratings
Strong Buy
16 Buy
3 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
REGN Stock 12 Month Forecast
Average Price Target
$951.25
▲(54.17% Upside)
| Highest Price Target$1,182 | Average Price Target$951.25 | Lowest Price Target$575.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Leerink Partners
Reiterated
04/01/25
J.P. Morgan
Reiterated
03/31/25
BMO Capital
Reiterated
03/14/25
TD Cowen
Reiterated
03/06/25
Canaccord Genuity
Reiterated
02/25/25
Guggenheim
Reiterated
02/11/25
Evercore ISI
Reiterated
02/07/25
Bank of America Securities
Reiterated
02/05/25
Truist Financial
Reiterated
02/05/25
Oppenheimer
$950
Buy
53.97%
Upside
Reiterated
02/05/25
Oppenheimer Sticks to Their Buy Rating for Regeneron (REGN)
Robert W. Baird
$940→$759
Hold
23.01%
Upside
Reiterated
02/05/25
Regeneron price target lowered to $759 from $940 at BairdRegeneron price target lowered to $759 from $940 at Baird
Wells Fargo
$900
Buy
45.87%
Upside
Reiterated
02/04/25
Regeneron: Strategic Growth and Pipeline Catalysts Justify Buy Rating
Morgan Stanley
$1,185→$1,150
Buy
86.39%
Upside
Reiterated
02/04/25
Regeneron Pharma (REGN) PT Lowered to $1,150 at Morgan StanleyMorgan Stanley analyst Matthew Harrison lowered the price target on Regeneron Pharma (NASDAQ: REGN) to $1,150.00 (from $1,185.00) while maintaining a Overweight rating.
RBC Capital
$1,059→$1,045
Buy
69.37%
Upside
Reiterated
02/04/25
RBC Capital Reaffirms Their Buy Rating on Regeneron (REGN)
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Leerink Partners
Reiterated
04/01/25
J.P. Morgan
Reiterated
03/31/25
BMO Capital
Reiterated
03/14/25
TD Cowen
Reiterated
03/06/25
Canaccord Genuity
Reiterated
02/25/25
Guggenheim
Reiterated
02/11/25
Evercore ISI
Reiterated
02/07/25
Bank of America Securities
Reiterated
02/05/25
Truist Financial
Reiterated
02/05/25
Oppenheimer
$950
Buy
53.97%
Upside
Reiterated
02/05/25
Oppenheimer Sticks to Their Buy Rating for Regeneron (REGN)
Robert W. Baird
$940→$759
Hold
23.01%
Upside
Reiterated
02/05/25
Regeneron price target lowered to $759 from $940 at BairdRegeneron price target lowered to $759 from $940 at Baird
Wells Fargo
$900
Buy
45.87%
Upside
Reiterated
02/04/25
Regeneron: Strategic Growth and Pipeline Catalysts Justify Buy Rating
Morgan Stanley
$1,185→$1,150
Buy
86.39%
Upside
Reiterated
02/04/25
Regeneron Pharma (REGN) PT Lowered to $1,150 at Morgan StanleyMorgan Stanley analyst Matthew Harrison lowered the price target on Regeneron Pharma (NASDAQ: REGN) to $1,150.00 (from $1,185.00) while maintaining a Overweight rating.
RBC Capital
$1,059→$1,045
Buy
69.37%
Upside
Reiterated
02/04/25
RBC Capital Reaffirms Their Buy Rating on Regeneron (REGN)
REGN Analyst Recommendation Trends
Rating
Dec 24
Jan 25
Feb 25
Mar 25
Apr 25
Strong Buy
7
17
21
17
6
Buy
31
21
17
19
11
Hold
9
11
9
8
3
Sell
2
3
3
2
1
Strong Sell
0
0
0
0
0
total
49
52
50
46
21
Each month's total comprises the sum of three months' worth of ratings.
REGN Financial Forecast
REGN Stock Forecast FAQ
What is REGN’s average 12-month price target, according to analysts?
Based on analyst ratings, Regeneron’s 12-month average price target is $951.25.
What is REGN’s upside potential, based on the analysts’ average price target?
Regeneron has 54.17% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is REGN a Buy, Sell or Hold?
Regeneron has a consensus rating of Strong Buy which is based on 16 buy ratings, 3 hold ratings and 1 sell ratings.
What is Regeneron’s price target?
The average price target for Regeneron is $951.25. This is based on 20 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $1,182.00 ,the lowest forecast is $575.00. The average price target represents 54.17% Increase from the current price of $617.
The highest analyst price target is $1,182.00 ,the lowest forecast is $575.00. The average price target represents 54.17% Increase from the current price of $617.
What do analysts say about Regeneron?
Regeneron’s analyst rating consensus is a Strong Buy. This is based on the ratings of 20 Wall Streets Analysts.
How can I buy shares of REGN?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.